LFST LifeStance Health Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFST

Price (delayed)

$6.66

Market cap

$2.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.51

Enterprise value

$2.96B

Highlights
The company's gross profit rose by 27% YoY and by 7% QoQ
The revenue has grown by 23% YoY and by 5% from the previous quarter
The quick ratio has grown by 26% from the previous quarter but it has contracted by 15% YoY
The debt has grown by 7% YoY and by 5% from the previous quarter
LifeStance Health Group's equity has decreased by 6% YoY
Sector: Healthcare
Industry: Medical Care Facilities

Key stats

What are the main financial stats of LFST
Market
Shares outstanding
380.69M
Market cap
$2.54B
Enterprise value
$2.96B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.76
Price to sales (P/S)
2.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.81
Earnings
Revenue
$1.06B
EBIT
-$185.36M
EBITDA
-$64.94M
Free cash flow
-$57.4M
Per share
EPS
-$0.51
Free cash flow per share
-$0.16
Book value per share
$3.77
Revenue per share
$2.87
TBVPS
$1.62
Balance sheet
Total assets
$2.11B
Total liabilities
$681.04M
Debt
$508.12M
Equity
$1.43B
Working capital
$22.86M
Liquidity
Debt to equity
0.36
Current ratio
1.11
Quick ratio
1.01
Net debt/EBITDA
-6.61
Margins
EBITDA margin
-6.2%
Gross margin
28.6%
Net margin
-17.6%
Operating margin
-17.9%
Efficiency
Return on assets
-8.6%
Return on equity
-12.7%
Return on invested capital
-22%
Return on capital employed
-9.7%
Return on sales
-17.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFST stock price

How has the LifeStance Health Group stock price performed over time
Intraday
1.99%
1 week
7.42%
1 month
10.08%
1 year
-17.37%
YTD
-14.94%
QTD
7.94%

Financial performance

How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.06B
Gross profit
$302.1M
Operating income
-$189.13M
Net income
-$186.26M
Gross margin
28.6%
Net margin
-17.6%
The net margin has grown by 30% YoY and by 6% from the previous quarter
The company's gross profit rose by 27% YoY and by 7% QoQ
The operating margin has increased by 27% year-on-year and by 11% since the previous quarter
The revenue has grown by 23% YoY and by 5% from the previous quarter

Growth

What is LifeStance Health Group's growth rate over time

Valuation

What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.76
P/S
2.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.81
LFST's EPS is up by 16% year-on-year
LFST's price to book (P/B) is 14% lower than its last 4 quarters average of 2.0
LifeStance Health Group's equity has decreased by 6% YoY
The revenue has grown by 23% YoY and by 5% from the previous quarter
The price to sales (P/S) is 22% less than the last 4 quarters average of 2.9

Efficiency

How efficient is LifeStance Health Group business performance
LFST's return on invested capital is up by 45% year-on-year and by 8% since the previous quarter
LFST's return on sales is up by 29% year-on-year and by 12% since the previous quarter
LifeStance Health Group's return on assets has increased by 20% YoY
LifeStance Health Group's return on equity has increased by 10% YoY

Dividends

What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFST.

Financial health

How did LifeStance Health Group financials performed over time
The quick ratio has grown by 26% from the previous quarter but it has contracted by 15% YoY
LFST's current ratio is down by 17% YoY
The debt is 64% less than the equity
The debt to equity has grown by 16% YoY and by 9% from the previous quarter
The debt has grown by 7% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.